Skip to main content

RDY Competitors

profileAnalyst coverage5 yr. financialspremium researchdividendsadv. chartsearningsoptionsprice historyeventsinsiders

Dr. Reddy's Laboratories Ltd News

Amarin Jumps on Heart-Drug Progress in China Trial

Amarin's cardiovascular-disease treatment Vascepa met its key endpoint in a late-stage trial in China.

51Job, U.S. Steel, Sorrento: 5 Top Stock Gainers Thursday

51Job, Herman Miller, Sorrento Therapeutics, Dr. Reddy Laboratories and U.S. Steel are among the top stock gainers for Thursday.

Amarin Loses Appeal in Heart Treatment Patent Case

The U.S. Court of Appeals makes its ruling one day after hearing arguments in the case.

Amarin Shares Off - Analysts Mull Prospects of Patent-Case Appeal

Amarin shares are lower after analysts assessed how the judges in the company's patent-case appeal might rule.

Amarin Shares Crushed After Judge Rules Heart Drug Patents Invalid: Report

Pharmaceutical maker Amarin sees shares lose more than half their value in late trading following adverse ruling in federal court.

Breaking News

Stock Market Today - 6/29: Stocks End Mixed As Recession Concerns Mount

Stocks ended mixed Wednesday as growth bets gave way to recession fears.

Should I Buy a House Now? (It's Personal and Complicated)

Mortgage rates are up and some markets have cooled down, but the reality is that the decision is very personal.

Crypto Crash Exposes Robinhood and Coinbase To Predators

A year can be a lifetime in the cryptocurrency world as major players are reeling from heavy losses.

Micron Earnings Preview: Will Critical Support Hold?

Micron is set to report earnings on Thursday after the close, but the stock sits on critical support. Will it hold or will it fold?